Position in ZTS
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$574
+$71 QoQ
Shares Held
8
+100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1,386
of 1,412 holders
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Davis Capital Management holds $13,097 across 13 Drug Manufacturers - Specialty & Generic names. ZTS ranks #2 (4.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALKS |
Alkermes plc.
|
212 | $11,107 | |
| 2 | ZTS |
Zoetis Inc.
This page
|
8 | $574 | |
| 3 | LQDA |
Liquidia Corp
|
4 | $318 | |
| 4 | INDV |
Indivior Pharmaceuticals, Inc.
|
7 | $287 | |
| 5 | AMRX |
Amneal Pharmaceuticals, Inc.
|
10 | $173 | |
| 6 | PBH |
Prestige Consumer Healthcare Inc.
|
3 | $141 | |
| 7 | SUPN |
Supernus Pharmaceuticals, Inc.
|
3 | $139 | |
| 8 | PRGO |
PERRIGO Co plc
|
8 | $83 |
All Filings in ZTS
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $574 | 8 | Shares | Sole | 2026-07-16 | |
| 2025-12-31 | $503 | 4 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $438 | 3 | Shares | Sole | 2025-10-21 | |
| No filing history on record for this holder in this stock. | ||||||